Economic and Clinical Impact of Using Human Milk–Derived Fortifier in Very Low Birth Weight Infants

Manas Tetarbe,Millie Rocio Chang,Lorayne Barton,Rowena Cayabyab,Rangasamy Ramanathan
DOI: https://doi.org/10.1089/bfm.2023.0163
2024-02-01
Breastfeeding Medicine
Abstract:Background: Implementation of exclusive human milk (EHM) feeding defined as mother's own milk or donor human milk fortified with human milk–derived fortifiers can place an economic burden on institutions. Methods: Retrospective study of very low birth weight (VLBW) infants before and after the implementation of EHM feedings. Neonatal demographics and clinical outcomes including necrotizing enterocolitis, severe retinopathy of prematurity, bronchopulmonary dysplasia, late-onset sepsis, days on parenteral nutrition (PN), and length-of-stay were collected. The net cost to the institution was estimated using published data. Results: Sixty-four infants in the pre-EHM period and 57 infants in the post-EHM period were enrolled. Net product acquisition cost in 2020 and 2021 was 1,813,444 ( 913,840 ($16,032 per infant). Conclusion: Implementation of EHM-based feeding in VLBW infants is a cost-effective option for neonatal intensive care units that can result in reduced length of stay and days on PN without adversely impacting short-term morbidities.
pediatrics,obstetrics & gynecology
What problem does this paper attempt to address?